Astrana Health, Inc. (NASDAQ:ASTH) Receives $47.86 Consensus Target Price from Analysts

Astrana Health, Inc. (NASDAQ:ASTH) has earned an average rating of “Moderate Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $47.8571.

A number of research firms have issued reports on ASTH. Needham & Company LLC boosted their price objective on shares of Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a report on Friday, May 8th. Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $37.00 to $50.00 in a research report on Tuesday, May 26th. Weiss Ratings upgraded Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. BTIG Research increased their price target on Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, Truist Financial raised their price objective on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Royal Bank of Canada lifted its position in Astrana Health by 6.5% during the first quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock worth $8,640,000 after purchasing an additional 17,028 shares during the period. AQR Capital Management LLC acquired a new stake in Astrana Health during the first quarter worth about $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Astrana Health by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock valued at $799,000 after buying an additional 1,263 shares during the period. Jones Financial Companies Lllp increased its holdings in Astrana Health by 4,365.2% in the 1st quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock valued at $346,000 after buying an additional 10,913 shares during the period. Finally, Intech Investment Management LLC raised its position in shares of Astrana Health by 5.8% in the 1st quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock valued at $1,383,000 after buying an additional 2,462 shares in the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Stock Performance

Shares of NASDAQ ASTH opened at $38.19 on Friday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a market cap of $2.13 billion, a price-to-earnings ratio of 62.61 and a beta of 0.89. The stock’s fifty day moving average price is $41.76 and its two-hundred day moving average price is $31.97. Astrana Health has a one year low of $18.08 and a one year high of $51.60.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. During the same quarter in the previous year, the business posted $0.42 earnings per share. Astrana Health’s quarterly revenue was up 55.6% on a year-over-year basis. On average, equities analysts forecast that Astrana Health will post 1.25 EPS for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.